Glaucoma Screening With Artificial Intelligence

Launched by THE UNIVERSITY OF HONG KONG · Aug 21, 2023

Keywords

ClinConnect Summary

This clinical trial is looking at how well two different artificial intelligence (AI) methods can detect glaucoma, a condition that can damage your eyesight. The researchers want to see if one method called ROTA (which analyzes the texture of the eye's nerve fibers) is better at identifying glaucoma compared to a standard method that takes pictures of the optic disc (the part of the eye where the optic nerve connects). They will also compare ROTA to another technique called OCT that measures the thickness of the nerve fibers, and look into how cost-effective using AI for screening is. Additionally, they want to find out how common glaucoma is in Hong Kong.

To participate in this trial, you need to be at least 50 years old. However, if you have difficulty moving around or can't cooperate during the eye exams, you won't be eligible. If you join the study, you can expect to undergo some eye tests using these AI methods, helping researchers learn more about detecting glaucoma. This research is important as it may lead to better, more efficient ways to screen for glaucoma, potentially helping many people maintain their vision.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Individuals aged 50 years or above
• Exclusion Criteria:
• • Physically incapacitated
• • Not able to cooperate for clinical examination or optical coherence tomography (OCT) investigation will be excluded